Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

Francesca Saluzzo; Seda Yerlikaya; Susan Elizabeth Dorman; Kathleen Eisenach; Maha Reda Farhat; Nazir Ismail; Christian Lienhardt; Timothy M Walker; Fatima Jones; Ana Yepes; Adam Penn-Nicholson; Morten Ruhwald; Bavesh Kana; Claudia Maria Denkinger; Daniela Maria Cirillo

doi:10.1016/S1473-3099(25)00547-X

Retour

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

Article de revue

Avec comité de lecture

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

Francesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, Kathleen Eisenach, Maha Reda Farhat, Nazir Ismail, Christian Lienhardt, Timothy M Walker, Fatima Jones, Ana Yepes, …

The Lancet infectious diseases

2025

DOI: https://doi.org/10.1016/S1473-3099(25)00547-X

Indicateurs

1 Consultations de la notice

Détails

Titre: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development
Créateurs - sans rôle: Francesca Saluzzo
Seda Yerlikaya
Susan Elizabeth Dorman
Kathleen Eisenach
Maha Reda Farhat
Nazir Ismail
Christian Lienhardt
Timothy M Walker
Fatima Jones
Ana Yepes
Adam Penn-Nicholson
Morten Ruhwald
Bavesh Kana
Claudia Maria Denkinger
Daniela Maria Cirillo
Détails de publication: The Lancet infectious diseases
Identifiants: 99158560709311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article